The outcome of regulatory inspections is critical to an organization’s success. The FDA performs inspections to check that companies are maintaining compliance with applicable regulations and quality standards. Though you do your best to avoid it, receiving a 483 or Warning Letter is inevitable. It’s important to take the observations very seriously because you only have 15 days to submit the subsequent responses.
But ensuring that you are aware and understand what the regulatory agency is expecting in the response can be a challenge. What should you include? What are the risks of not submitting an appropriate response?
This 90-minute course will discuss the importance of developing and submitting a robust, timely response to FDA 483 observations or warning letters; as well as, educate the audience on the essential elements of a thorough response. Additionally, this course will review the proper structure of the response to ensure the regulatory agency’s expectations are met and the submission process.
At the completion of this session, you will be able to:
This course will be valuable to anyone engaged in the development, manufacturing, sale, or distribution of FDA-regulated healthcare products. Additionally, this course will provide a good primer for those involved in writing observation responses. This includes personnel in:
At the completion of this session, you will be able to:
This course will be valuable to anyone engaged in the development, manufacturing, sale, or distribution of FDA-regulated healthcare products. Additionally, this course will provide a good primer for those involved in writing observation responses. This includes personnel in:
Kelly Thomas
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
2025 Handbook Overhaul: Navigating Critical Updates! Federa…
Dealing With Difficult People In Life & Work
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Copilot and HR: An Introduction for HR Professionals
Beat Workplace Burnout: 10 Proven Techniques to Manage Your…
Workplace Investigations Uncovered: Best Practices and Stra…
Employers Should Prepare for Immigration Raids in 2025! Thi…
Managing Toxic Employees: Strategies For Leaders To Effecti…
Keys to Captivating an Audience: Informing and Inspiring t…
Do's and Don'ts of Documenting Employee Behaviour, Performa…
Understanding Artificial Intelligence (AI) & using Chat GPT
Transform Data into Insights: A Beginners Guide to Excel Pi…
Empowering Conflict Resolution: Letting Go to Gain Control
Outlook - Master your Mailbox - Inbox Hero Inbox Zero
Bootcamp for New Managers and Supervisors: Develop These Es…
Project Management for administrative professionals
Negotiating Skills For Professional Results - Winning Strat…
How to Write Effective Audit Observations: The Principles f…
How to Use ChatGPT to Write Employee Evaluations
Power BI - Getting Started Building Reports and Dashboards
3-Hour Virtual Boot Camp on Easier Excel Automation with VB…
Onboarding is NOT Orientation - How to Improve the New Empl…
How to Conduct Exit Interviews - Implementing and Enhancing…
Onboarding Best Practices for 2025: Proven Strategies to Po…
Form W-9 Compliance: TIN Verification, B Notices, and Avoid…
The Five Cs Of Commercial Credit: The Basic Elements Of Cre…
2025 EEOC & Employers: Investigating Claims of Harassment …
2-Hour Virtual Seminar on How to Conduct an Internal Harass…